Genzyme inaugurates Middle East office in Dubai

Notes and media contacts

About Genzyme
One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. This year marks the 25th anniversary of Genzyme's founding. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 8,500 employees in locations spanning the globe and 2005 revenues of $2.7 billion. Genzyme has been selected by FORTUNE as one of the "100 Best Companies to Work for" in the United States. With many established products and services helping patients in more than 80 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune diseases, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as heart disease and other areas of unmet medical need.

For more information about Genzyme, please consult www.genzyme.com.

About DuBiotech

The Dubai Biotechnology and Research Park (DuBiotech), launched in February 2005, is the region's first and foremost science and Business Park dedicated entirely to the global life science industry. DuBiotech aims to be the central hub for all life science industries for the greater Middle East. DuBiotech offers a vibrant environment for key players of such industries to thrive. The park offers drug manufacturers and industry specific service providers all the support needed to make their presence at DuBiotech an efficient and effective process. Such service providers include suppliers of laboratory equipment and reagents, venture capital firms, design consultants, etc. Apart from the headquarters and its state-of-the-art laboratory complexes, DuBiotech additionally offers a unique environment where companies can truly capture and serve their target market in a setting that reflects DuBiotech's dedication to exceptional architecture and practicality with an emphasis towards the requirements of life science companies. A central focus of DuBiotech is research, and to support the drive toward setting a park dedicated to research excellence, DuBiotech has established the Foundation for Research and Innovation (FRI). The FRI will initially focus on medical, industrial, environmental and agricultural biotechnology. DuBiotech is governed by world class regulations in line with those applied to the top life science clusters globally. By working closely with the industry, federal authorities and world IP bodies, DuBiotech will ensure that existing IP laws and regulations are strictly enforced. DuBiotech attaches considerable importance to Intellectual Property issues, considering the sensitive nature of work done within this industry. As part of TECOM's corporate social responsibility, all DuBiotech's buildings are to be classified as LEED certified 'Green' buildings.

For further information about DuBiotech:
Baiju Francis
Account Manager
JIWIN, The Public Relations Arm of Dubai Press Club
T:+9714 361 3 596
F:+9714 368 8 001
M:+97150 7971996